bit.bio launches first supply of consistent, scalable, human muscle cells
Highly consistent and scalable supply of lab grown human skeletal muscle cells provide an effective and biologically relevant tool for research and drug development
Highly consistent and scalable supply of lab grown human skeletal muscle cells provide an effective and biologically relevant tool for research and drug development
Gain insights on topics from immunotyping and cell sorting to clinical QC, 3D imaging and more
Diadem announces publication of clinical data showing its AlzoSure biomarker test is able to predict progression to Alzheimer’s disease years before symptoms are displayed.
Talks from world-leading scientists in the field of neuroscience now available on demand
Watch this on-demand webinar to discover Abcam’s manufacturing workflow for producing bioactive proteins
Teams uses mathematical modelling study to guide preparations for future health strategies
A first of its kind study demonstrates voltage outside of biological cells, with potential implications for cardiovascular disease, cancer and fertility treatment
Including a new section for embedded organoid assays, and new data on mitochondrial membrane potential assays and phagocytosis assays
New life sciences brand enables breakthroughs to market with a fully integrated portfolio which promises unparalleled sample exploration and management solutions
Abcam scientist, Dr. Jimmy Theriault, discusses how to determine if proteins are functionally active using cell-based and biochemical assays
The panels complete Bio-Rad’s set of Bio-Plex™ Pro Multiplex SARS-CoV-2 Human Serology Panels for detection of antibodies against four SARS-CoV-2 antigens
Gain insights on topics from antibody performance and cell line development to food safety method validation and more
New module is designed to provide life science researchers with high-resolution images
The FDA cleared the first new major technological improvement for Computed Tomography (CT) imaging in nearly 10 years
Latest technologies aim to improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell and gene therapy, autoimmune disease and drugs of abuse
Customers will benefit from enhanced development and manufacturing capabilities, including high-density microarray printing
Measurement of anti-S1/RBD antibodies, neutralizing antibodies targeting S1/RBD, and specific T-cells using Euroimmun tests supports evaluation of the immune reaction to SARS-CoV-2 following vaccination or infection
Introduced at AACC, the VeraPrep Antibody Detection Kit enables researchers to measure antibodies against any antigen of interest in serum, plasma or saliva
Two new studies reveal how antibodies against the SARS-CoV-2 virus can vary between individuals
The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance
Novel RHINOstic swab collection device and automated liquid handlers increase testing throughput while decreasing active manpower